Prostatis Group’s Panagram BBB-B CLO ETF CLOZ Stock Holding History
Bought
Maintained
Sold
Other funds holding CLOZ
AAP
SBLIC
EPG
GFP
AI
SIS
Prostatis Group's CLOZ Position: Q2 2026 in Review
Prostatis Group reduced its Panagram BBB-B CLO ETF (CLOZ) stake by 0.02% in Q2 2026, selling an estimated $52 and leaving 12,484 shares worth $330K. The position accounts for 0.08% of the portfolio, ranked #137.
Prostatis Group first reported a position in CLOZ in Q4 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold CLOZ as of Q2 2026.
- Prostatis Group held 12,484 shares of Panagram BBB-B CLO ETF worth $330K as of Q2 2026.
- Prostatis Group sold 2 Panagram BBB-B CLO ETF shares in Q2 2026, an estimated $52.
- Panagram BBB-B CLO ETF made up 0.08% of Prostatis Group's portfolio in Q2 2026, its #137 holding.
- Prostatis Group first reported a position in Panagram BBB-B CLO ETF in Q4 2025 and has held it in 3 quarters since.
- 93 funds tracked by Wall St. Rank held Panagram BBB-B CLO ETF as of Q2 2026.
Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.